TOKENPOST
1 min read
Add as a preferred source on Google

Vera Therapeutics Q3 Revenue Tops Estimates by $6.88 Million

The company posted $10.2 million in revenue, while its GAAP loss was $1.30 per share, 32 cents narrower than estimates.

By John Kim
Published
A clear laboratory vial balances beside a polished metal weight / TokenPost.ai
A clear laboratory vial balances beside a polished metal weight / TokenPost.ai

Vera Therapeutics, Inc. (NASDAQ: VERA) posted $10.2 million in third-quarter revenue, beating estimates by $6.88 million, while its GAAP loss per share was narrower than expected.

The company’s GAAP loss was $1.30 per share, 32 cents narrower than estimates.

John Kim

John Kim reports on the digital-asset business for TokenPost. Send corrections or tips to info@tokenpost.com.

Loading…